Viridian Therapeutics Inc Ordinary Shares VRDN 深 滬
已收盤 10-31 16:00:00 美东时间
23.63
-0.030
-0.13%
華盛通- 最 高24.045
- 今 開23.74
- 成交量 130.68万股
- 最 低 23.35
- 昨 收 23.66
- 總市值 19.30亿
- 52周最高 27.20
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 9.90
- 委 比 50.37%
- 總股本 8166.24万
- 歷史最高 270.00
- 量 比 0.89
- 振 幅 2.94%
- 歷史最低 4.665
- 每 手 1
- 風險率 3.17%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多瑞银：首予再鼎医药“买入”评级 近期具明确催化剂但被低估
瑞银发布研报称，基于现金流折现法（DCF），对再鼎医药（09688）目标价为33.5港元，分别意味着1倍、1.6倍未调整/调整后价格对高峰销售。瑞银认为，市...
10-27 14:09
Viridian Therapeutics prices $251M share offering
Viridian Therapeutics (NASDAQ:VRDN) priced an underwritten public offering of shares, selling a total of ~11.43M shares at $22.00 per share. The underwriters have a 30-day option to purchase an addi...
10-22 14:29
Viridian Therapeutics Launches An Underwritten Public Offering Of Its Common Stock And Series B Non-Voting Convertible Preferred Stock; Financial Terms Not Disclosed
Viridian Therapeutics, Inc. (NASDAQ:VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today announced that it has
10-22 04:03
Viridian Therapeutics Secures $300M Deal with DRI Healthcare
The latest announcement is out from Viridian Therapeutics ( ($VRDN) ). On Octob...
10-21 02:49
Viridian Therapeutics announces inducement grants under Nasdaq listing rule 5635(c)(4)
Viridian Therapeutics (NASDAQ:VRDN) announced that its compensation committee has approved the grant of non-qualified stock options to purchase 147,650 shares of its common stock to four new employees...
10-03 04:11
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
09-30 01:35
Viridian Therapeutics (VRDN) Receives a Buy from Jefferies
Jefferies analyst Kelly Shi initiated coverage with a Buy rating on Viridian Th...
08-25 19:26
百济盈利，再鼎环比翻倍，信达收入52亿，股价却齐跌？创新七君进入重估时刻
对于以“创新七君”为代表的中国头部Biotech来说，已在2024年年报披露时普遍站上盈亏平衡线，2025年则不再是验证能否盈利的一年，而是走进拐点的新周期...
08-13 21:59
美股大行评级 | DoorDash获上调目标价从230美元升至300美元； 摩根大通上调Shopify目标价从115美元升至179美元
今日重点评级关注：HC Wainwright & Co.：维持FibroGen"买入"评级，目标价从10美元升至43美元；摩根大通：维持Cogent Biosciences"超配"评级，目标价从29美元升至30美元
08-08 09:34
These Analysts Revise Their Forecasts On Viridian Therapeutics Following Q2 Results
Viridian Therapeutics, Inc. (NASDAQ:VRDN) reported upbeat results for the secon...
08-08 02:37
